Iradimed (IRMD) Cash from Operations (2013 - 2026)

Iradimed (IRMD) has 14 years of Cash from Operations data on file, last reported at 8290000.0 in Q1 2026.

• Cash from Operations for Q1 2026 came in at 8290000.0, up 93.15% year-over-year; the trailing twelve-month figure through Mar 2026 was 28945000.0 (up 11.19% YoY), and the FY2025 annual result was 24947000.0, down 2.64% from the prior year.
• Cash from Operations grew to 8290000.0 in Q1 2026 per IRMD's latest filing, from 5922572.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 9115714.0 in Q3 2024 and troughed at 1392684.0 in Q3 2023.
• A 5-year average of 4845219.0 and a median of 4292000.0 in 2025 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations sank 64.64% in 2023, then surged 554.54% in 2024.
• A 5-year view of Cash from Operations shows it stood at 3038844.0 in 2022, then climbed by 28.75% to 3912480.0 in 2023, then soared by 53.01% to 5986606.0 in 2024, then decreased by 1.07% to 5922572.0 in 2025, then jumped by 39.97% to 8290000.0 in 2026.
• Business Quant data shows IRMD's Cash from Operations at 8290000.0 in Q1 2026, 5922572.0 in Q4 2025, and 6986075.0 in Q3 2025.